Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Vasiliki Rapti"'
Autor:
Ioannis Grigoropoulos, Georgios Tsioulos, Artemis Kastrissianakis, Shiran Shapira, Orr Green, Vasiliki Rapti, Maria Tsakona, Thomas Konstantinos, Athina Savva, Dimitra Kavatha, Dimitrios Boumpas, Konstantinos Syrigos, Ioannis Xynogalas, Konstantinos Leontis, Vasileios Ntousopoulos, Vissaria Sakka, Zafeiris Sardelis, Andreas Fotiadis, Lamprini Vlassi, Chrysoula Kontogianni, Anastasia Levounets, Garyfalia Poulakou, Mina Gaga, Ronan MacLoughlin, Justin Stebbing, Nadir Arber, Anastasia Antoniadou, Sotirios Tsiodras
Publikováno v:
Respiratory Research, Vol 25, Iss 1, Pp 1-13 (2024)
Abstract Introduction EXO-CD24 are exosomes genetically manipulated to over-express Cluster of Differentiation (CD) 24. It consists of two breakthrough technologies: CD24, the drug, as a novel immunomodulator that is smarter than steroids without any
Externí odkaz:
https://doaj.org/article/24f5adc7c431420c90c68b1ab0f43b4a
Autor:
Vasiliki Rapti, Garyfallia Poulakou, Anastasia Mousouli, Athanasios Kakasis, Stamata Pagoni, Evmorfia Pechlivanidou, Aikaterini Masgala, Styliani Sympardi, Vasileios Apostolopoulos, Charalampos Giannopoulos, Nikolaos Alexiou, Kostoula Arvaniti, Christina Trakatelli, Apostolos Prionas, Michael Samarkos, George L. Daikos, Helen Giamarellou
Publikováno v:
Antibiotics, Vol 13, Iss 9, p 812 (2024)
Antimicrobial resistance poses a major threat to human health worldwide and the implementation of antimicrobial stewardship programs (ASPs), including antimicrobial de-escalation (ADE), is a multifaceted tool for minimizing unnecessary or inappropria
Externí odkaz:
https://doaj.org/article/6d9be285b92a4844810f0979dd97c1d1
Publikováno v:
Pathogens, Vol 12, Iss 12, p 1444 (2023)
Since its first description in 2009, Candida auris has, so far, resulted in large hospital outbreaks worldwide and is considered an emerging global public health threat. Exceptionally for yeast, it is gifted with a profoundly worrying invasive potent
Externí odkaz:
https://doaj.org/article/990980a53ae446e28a75b96cd2ad04b5
Autor:
Nikos Pantazis, Evmorfia Pechlivanidou, Anastasia Antoniadou, Karolina Akinosoglou, Ioannis Kalomenidis, Garyfallia Poulakou, Haralampos Milionis, Periklis Panagopoulos, Markos Marangos, Ioannis Katsarolis, Pinelopi Kazakou, Vasiliki Dimakopoulou, Anna-Louiza Chaliasou, Vasiliki Rapti, Eirini Christaki, Angelos Liontos, Vasileios Petrakis, Georgios Schinas, Dimitrios Biros, Maria-Christina Rimpa, Giota Touloumi
Publikováno v:
Microorganisms, Vol 11, Iss 8, p 1998 (2023)
Remdesivir was the first antiviral approved for treating COVID-19. We investigated its patterns of use, effectiveness and safety in clinical practice in Greece. This is a retrospective observational study of hospitalized adults who received remdesivi
Externí odkaz:
https://doaj.org/article/4d7eb4bd99eb4872959707740bb6624a
Autor:
Christina Papanikolaou, Vasiliki Rapti, Dimitris Stellas, Dimitra T. Stefanou, Konstantinos Syrigos, George N. Pavlakis, Vassilis L. Souliotis
Publikováno v:
Vaccines, Vol 10, Iss 10, p 1764 (2022)
COVID-19 is an infectious disease caused by the SARS-CoV-2 coronavirus and characterized by an extremely variable disease course, ranging from asymptomatic cases to severe illness. Although all individuals may be infected by SARS-CoV-2, some people,
Externí odkaz:
https://doaj.org/article/8253c20091cf4cac9080dafa4b3044fa
Autor:
Vasilis Petrakis, Vasiliki Rapti, Karolina Akinosoglou, Constantinos Bonelis, Kalomoira Athanasiou, Vasiliki Dimakopoulou, Nikolaos K. Syrigos, Nikolaos Spernovasilis, Grigoris Trypsianis, Markos Marangos, Charalambos Gogos, Dimitrios Papazoglou, Periklis Panagopoulos, Garyfallia Poulakou
Publikováno v:
Microorganisms, Vol 10, Iss 10, p 1949 (2022)
In several randomized studies, remdesivir (RDV) has been reported to shorten the recovery period and improve clinical outcomes in COVID-19 patients, and thus, it is recommended as a standard of care. Nevertheless, controversial reports have been publ
Externí odkaz:
https://doaj.org/article/dc57e712b5e14c8ba7e4e29aa288743f
Autor:
Vasiliki Rapti, Thomas Tsaganos, Ioannis A. Vathiotis, Nikolaos K. Syrigos, Peifeng Li, Garyfallia Poulakou
Publikováno v:
Vaccines, Vol 10, Iss 10, p 1607 (2022)
Since the pandemic’s onset, a growing population of individuals has recovered from SARS-CoV-2 infection and its long-term effects in some of the convalescents are gradually being reported. Although the precise etiopathogenesis of post-acute COVID-1
Externí odkaz:
https://doaj.org/article/badf69c4e93d426ba0249d3590a11468
Autor:
Mina Psichogiou, Andreas Karabinis, Ioanna D Pavlopoulou, Dimitrios Basoulis, Konstantinos Petsios, Sotirios Roussos, Maria Pratikaki, Edison Jahaj, Konstantinos Protopapas, Konstantinos Leontis, Vasiliki Rapti, Anastasia Kotanidou, Anastasia Antoniadou, Garyphallia Poulakou, Dimitrios Paraskevis, Vana Sypsa, Angelos Hatzakis
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0243025 (2020)
IntroductionGreece is a country with limited spread of SARS-CoV-2 and cumulative infection attack rate of 0.12% (95% CI 0.06-0.26). Health care workers (HCWs) are a well-recognized risk group for COVID-19. The study aimed to estimate the seroprevalen
Externí odkaz:
https://doaj.org/article/25298d48c239474f90837d1aee6a26bb
Autor:
Petros Ioannou, Stamatis Karakonstantis, Anna Mathioudaki, Angelos Sourris, Vasiliki Papakosta, Periklis Panagopoulos, Vasilis Petrakis, Dimitrios Papazoglou, Kostoula Arvaniti, Christina Maria Trakatelli, Evgenia Christodoulou, Garyfallia Poulakou, Konstantinos N. Syrigos, Vasiliki Rapti, Konstantinos Leontis, Dimitrios Karapiperis, Diamantis P. Kofteridis
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 6, Iss 3, p 136 (2021)
Health care workers (HCWs) face a higher risk of infection, since they work at the front line of COVID-19 patients’ management. Misinterpretations of current scientific evidence among HCWs may impact the delivery of appropriate care to COVID-19 pat
Externí odkaz:
https://doaj.org/article/31d336ec0eb042f398835696fa5f3344
Publikováno v:
Frontiers in Public Health, Vol 7 (2019)
The recent expansion of multidrug resistant and pan-drug-resistant pathogens poses significant challenges in the treatment of healthcare associated infections. An important advancement, is a handful of recently launched new antibiotics targeting some
Externí odkaz:
https://doaj.org/article/80821bc9d0e94715953e2f50c560f217